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Introduction
It is known that endogenous nitric oxide (NO) is
affecting exocrine and endocrine pancreatic secretion
in humans [1]. However, NO production in cells,
exceeding the amount necessary for normal biological
activities, results in cell death by apoptosis and tissue
damage [2-4]. NO is produced by enzyme nitric oxide
synthase (NOS), which is a short-lived mediator that
can be produced in various cell types. Suppression of
NOS reduces pancreatic enzyme secretion, plasma
insulin and pancreatic polypeptide levels [1]. There are
three major types of NOS isoforms, two of them are
Ca2 +/calmodulin-dependent isoforms called neuronal
NOS (nNOS) and endothelial NOS (eNOS). These two
are also collectively called constitutive NOS (cNOS).
The third one is Ca2 +/ calmodulin independent iso-
form, inducible NOS (iNOS) [5]. As it can be deduced
from this common definition and labeling, while
cNOS is principally involved in regulation of normal
physiological activities, increasing iNOS expression
occurs during inflammatory process and some malign
transformations. It is mentioned in very few articles
that iNOS expression in pancreatic islet beta-cells
modulates endocrine cell functions [6]. However, there
is no sufficient number of research about constitutive
expression of iNOS under normal physiological condi-
tions.
It is claimed that iNOS is involved in diabetogene-
sis [7]. It is also believed that in insulin-dependent dia-
betes mellitus (IDDM),  possible mediator of pancre-
atic beta-cell damage is radical NO and iNOS is the
most involved of NOS isoforms in immune mediated
beta-cell damage [8]. High level of NO produced by
iNOS is related to pancreatic beta-cell disfunction and
apoptosis [2,3]. IDDM is characterized by inflamma-
tory reaction in and around Langerhans islets followed
by selective destruction of insulin producing beta-
cells. This inflammatory reaction is caused by
macrophages, monocytes, T and B lymphocytes and
natural killer cells [9]. These cells, being the humoral
mediators of immunologic process, produce and
release various cytokines. Cytokines are immunologi-
cal effector molecules responsible for inhibition of
insulin secretion from pancreatic beta-cells and induct-
ing beta-cell destruction [10]. It is clear that in islets
exposed to cytokines, there is a high level of iNOS
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expression, followed by overproduction of NO, how-
ever NO is necessary but not sufficient by itself in
cytokine-mediated selective beta-cell destruction [11]. 
The source of NO production which mediates islet
cell damage has been discussed, NO production in
beta-cells, macrophages, ductal cells, and endothelial
cells has been considered and it has been shown that
NO which induces damage on beta-cells may be pro-
duced in beta-cells [12]. In another research, contribu-
tion of ductal cells in this process (because they are
very close to beta-cells) has been analyzed, human
ductal cells have been cultured with various cytokines,
and comparison of the magnitude of iNOS mRNA
expression and nitric oxide production in these cells
with that in isolated human islets have shown that
more than half of the total NO production might orig-
inate from associated ductal cells. Relying on this data,
it has been claimed that ductal cells are a potantial
source of NO production in human islets which have
been infiltrated by cytokine-releasing immunocytes,
and in early stages of insulitis, ductal cells in periphery
of pancreatic islets might be a major target for
cytokines released by immunocytes [13]. 
Despite the common belief that the expression of
iNOS in beta-cell and following beta-cell destruction
is a response of beta-cells to cytokines, constitutive
presence of iNOS in pancreas and Langerhans islets
and the physiological amount has not been exactly elu-
cidated. Moreover, there is some research about iNOS
expression increase/decrease caused by other factors
(6). It has been observed that glucose stimulates islet
activities of cNOS and iNOS dose-dependently,
cNOS-derived NO inhibits glucose-stimulated insulin
release strongly, and that this short-term hyper-
glycemia in mice induces islet iNOS activity. Hyper-
glycemia-evoked islet NOS activity may be one of the
many factors of glucose-stimulated insulin release dis-
order in type II diabetes mellitus [14]. 
For survival of beta-cells which have been exposed
to proinflammatory cytokines, focusing on iNOS
expression may be useful [15]. It has been shown that
pharmacological inhibition of iNOS protects against
beta-cell damage both in vitro and in vivo, and reduces
the sensitivity of animals deficient in iNOS against
induction of diabetes [16-19]. However, it has also
been shown that cytokines induce beta-cell impair-
ment, independent of NO production [20-22]. iNOS is
one of the many factors in beta-cell destruction, thus
inhibition of it is not sufficient for prevention of dia-
betes [23]. In determining the role of iNOS in diabeto-
genesis, and conducting research about iNOS for dia-
betes prevention, it is necessary to shed some light on
constitutive expression of iNOS in pancreas and the
factors which can increase/decrease this expression. 
The aim of this study was to determine whether the
presence of iNOS immunoreactivity (iNOS-IR) and, if
so, to compare the iNOS-IR in islet of Langerhans
cells (LC),  acinar cells (AC), centroacinar cells (CC)
and ductal cells (DC) by immunohistochemical (IHC)
method in healthy rat pancreata.
Materials and methods
Animals and tissue samples. iNOS-IR in LC, AC, CC, and DC
was analyzed in formalin-fixed, paraffin-embedded sections by
IHC methods. Ten healthy female Wistar rats (10-12 weeks, 200 ±
20 g) were used. Animals had been housed in a colony room at an
ambient temperature of 22 ± 1°C, maintained under a 12:12 hour
light-dark cycle, and fed normal diet. The rats were sacrificed
under ether anesthesia and their pancreata were removed. All
experiments were conducted in compliance with the guidelines of
the Principles of Laboratory Animal Care (NIH publication No. 86-
23, revised 1985).
Samples processing and immunohistochemistry. Tissue samples
were fixed in 10% buffered formalin for 18 hours. After tissues
were fixed, samples were rinsed with phosphate buffered saline
(PBS), and the specimens were subsequently dehydrated in ethanol,
cleared in xylene and embedded in paraffin. Sections (5-6 μm) were
cut and mounted on glass slides. The sections were deparaffinized in
xylene, rehydrated in decreasing concentrations of ethanol and cov-
ered with 10 mM sodium citrate buffer (pH=6.0), heated at 95°C for
5 minutes, for antigen retrieval. Endogenous peroxidase activity was
quenched by 5 min. incubation in peroxidase blocking solution
(DBS Universal Immunostaining Kit, CA).
Tissues were then incubated with the rabbit polyclonal antibody
against iNOS (Chemicon, CA) for 2 hours and then in the biotiny-
lated secondary antibody for 10 minutes (DBS Universal ?mmunos-
taining Kit, CA). Negative controls were performed by substituting
the primary antibody with nonimmune rabbit serum. Immunoreac-
tivity was detected by means of horseradish-peroxidase (HRP)-
streptavidin complex using diaminobenzidine (DAB) chromogen as
a marker (DBS Universal Immunostaining Kit, CA). Sections were
counterstained in Mayer's hematoxylin for 30 seconds. Subsequent-
ly, the sections were rinsed and finally mounted (DBS CC/Mount,
CA). All steps were carried out at room temperature in a humidified
chamber. Assessments, counts and photography were performed by
a light microscope (Laborlux K, Leitz, Germany).
10 slides for each rat, a total of 100 slides prepared from the
pancreatic tissue samples, were evaluated. Initially, positive
immunostaining cells were counted in LC on the whole slide, and
the percentages were calculated. Next, positive and negative AC,
CC, and DC were counted in random microscopic areas of
exocrine pancreas,  in the same rat with the same magnification
power and with the same number of islets of Langerhans. Thus,
percentages within each cell types for each rat were calculated and
a single ratio was given. 
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Table 1. Distribution of iNOS immunoreactivity (iNOS-IR) in
islet of Langerhans cells (LC),  acinar cells (AC), centroacinar
cells (CC) and ductal cells (DC) in healthy rat pancreata.
The results of immunohistochemical staining were evaluated
semiquantitatively on the basis of a four-point scale: - negative
staining; + low expression, less than 10% of positive cells; ++
moderate expression 10-50% of positive cells; +++ diffuse expres-
sion, more than 50% of positive cells. 
Statistical analysis. Statistical analysis was performed using Pear-
son chi-square test. p values <0.05 were considered significant.
Results
Different levels of iNOS-IR positivity were detected in
3 different cell types, namely LC, CC and DC. In all
iNOS-IR positive cells, mediocre immunoreactivity
was observed. iNOS-IR was observed in almost all
LC, but surprisingly there was no immunoreactivity in
AC, or it was not intense enough to be detectable by
these methods. Sections serving as negative controls
were all unstained.
iNOS-IR in tissues was diffuse in100% of LC; dif-
fuse in 20%, moderate in 60%, and low in 20% of CC ;
diffuse in 80% and  moderate in 20% of  DC, iNOS-IR
was negative in 100% of AC (Fig. 1A and 1B), (Table 1).
Statistical analyses (Pearson chi-square test)
revealed a highly significant difference (p<0.001) with
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Fig. 1. Immunoreactivity for
iNOS in islet of Langerhans cells
(LC),  acinar cells (AC), cen-
troacinar cells (CC) and ductal
cells (DC) in pancreas of healthy
rat. Different levels of iNOS -IR
positivity were seen in LC, CC
and DC. No positive immunos-
taining was observed in AC.
Counterstained with hematoxylin;
original magnification × 160 (A)
and × 400 (B).
respect to iNOS-IR in comparison of all cell types.
However, binary comparison of cell types revealed no
significant differences between LC and DC (p=0.136);
significant differences LC and CC, CC and DC
(p=0.001 and 0.022, respectively) and a highly signif-
icant differences LC and AC, AC and DC (p<0.001). 
Discussion
In IDDM, autoimmune beta-cell destruction occurs
either directly by cell-mediated cytotoxicity or indi-
rectly by cytokines released from infiltrating lympho-
cytes. It is almost certain that proinflammatory
cytokines induce expression of iNOS, which produces
NO, resulting in beta-cells damage [23], and beta-cells
have been determined as the source of this NO [24].
Although NO induced by cytokines have toxic and
inhibitory effect on islets, NO produced under physio-
logical conditions contributes to cellular functions in
pancreatic beta-cells just like in other cells. It is not
determined which NOS isoform produces NO under
physiological conditions. Research results show that
cytokine-induced apoptosis is generally NO-indepen-
tent, but NO is necessary for necrosis [25] and
cytokines can induce both NO-dependent and NO-
independent inhibition of beta-cell function [26]. It is
claimed that beta-cell function disorder in rat pancre-
atic islets following intraveneous infusion of glucose
or intralipid, is at least partially madiated by induction
of iNOS [27]. This data shows that iNOS expression is
not solely dependent on cytokine induction but can be
affected by other factors. 
While there are many ongoing research which aim
to illimunate the role of iNOS in diabetogenesis [7]
and prove the benefits of iNOS inhibitor utilisation in
treatment and prevention of  diabetes [16-19], it should
be considered that expression mechanism of iNOS is
still not entirely elucidated. The results obtained by
this research show that in almost all of LC, iNOS-IR is
present in healthy pancreata.
The fact that there is no iNOS-IR in serous AC of
exocrin pancreas indicates that iNOS may be
expressed in cells related to cell functions. While there
is no iNOS-IR in AC, it is present in CC, which may
indicate that the presence of iNOS may be related to
cell localizations. 
Beta-cells and DC have been determined as the
source of iNOS which has been expressed as a result
of cytokine induction [12,13]. This research shows that
the most of the iNOS-IR in pancreas is present in LC
and DC. Further research is necessary to determine
which amount of iNOS in Langerhans islets is physio-
logical.
To conclude, it should be accepted that mainly
cytokines and some other possible factors may cause
overexpression of iNOS, which may result in beta-cell
destruction and diabetes. Especially in reseach related
to diabetes, it should not be disregarded that iNOS
which is considered as the main factor in islet beta-cell
destruction,  is also constitutively present in pancreat-
ic islets. The presence of iNOS in pancreas may vary
with species, affected by environmental factors, and
also vary with cell functions and cell localizations. 
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